ILYA Pharma logo β€” Ilya Pharma πŸ‡ΈπŸ‡ͺπŸ‡ΊπŸ‡Έ is bringing local-acting immunotherapies to...

ILYA Pharma

Ilya Pharma πŸ‡ΈπŸ‡ͺπŸ‡ΊπŸ‡Έ is bringing local-acting immunotherapies to patients

Founded 2016 Sweden Sweden 15 employees Grant Total: $15.79M Biotechnology, Health Care +1

General Information

Company Name ILYA Pharma
Founded Year 2016
Location Sweden Sweden
Employees 15
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with ILYA Pharma. To contact ILYA Pharma, visit ilyapharma.se.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ILYA Pharma compare?

A PDF of ILYA Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ILYA Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ILYA Pharma

Ilya Pharma is a biotechnology company founded in 2016 with a unique focus on bringing local-acting immunotherapies to patients. Headquartered in Sweden, the company has garnered attention for its innovative approach in the healthcare and pharmaceutical industries. Ilya Pharma received a grant investment from EIT Health on 09 July 2020, showcasing strong support from notable investors. With its commitment to advancing immunotherapy and localized treatment, Ilya Pharma stands out as a promising player in the biotechnology sector, aiming to deliver impactful solutions for patients in need.

Business keywords: Biotech, Immunotherapy, Pharmaceuticals, Medical Research, Biopharmaceuticals, Drug Development, Healthcare Innovation

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
EIT Health
09 Jul 2020
Venture Round €3.94M 1
European Innovation Council
10 Jun 2020
Grant €1.36M 1
European Innovation Council
10 Jun 2020
Venture Round €3.00M -
10 Sep 2018
Grant €2.99M 1
EASME - EU Executive Agency for SMEs
30 Nov 2017
Venture Round kr4.50M -
08 Aug 2017

ILYA Pharma Alternatives & Competitors

View All Alternatives
ILYA Pharma vs

ImmunAbs Inc. is Specialized Antibody Pharmaceutical Development Biotech Venture. "Hope for Patient...

Series B
11 employees
Biotechnology, Health Care
ILYA Pharma vs
Candid Therapeutics
Candid Therapeutics United States

Developing innovative therapeutics that can materially improve the lives of patients

Acquired
46 employees
Biotechnology, Pharmaceutical
ILYA Pharma vs

A New Generation Biotech Company

Grant
8 employees
Biotechnology, Health Care

FAQ About ILYA Pharma

Ilya Pharma πŸ‡ΈπŸ‡ͺπŸ‡ΊπŸ‡Έ is bringing local-acting immunotherapies to patients
ILYA Pharma was founded in 2016.
ILYA Pharma is headquartered in Sweden.
ILYA Pharma operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Biotech, Immunotherapy, Pharmaceuticals and Medical Research.
ILYA Pharma has approximately 15 employees.
ILYA Pharma has completed 6 funding rounds, raising a total of $15.79M. The latest funding stage is Grant.
Top alternatives and competitors to ILYA Pharma include ImmunAbs Inc., Candid Therapeutics, ABIONYX Pharma, Dracen Pharmaceuticals, Inc., iN Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ILYA Pharma and ImmunAbs Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ILYA Pharma, https://bouncewatch.com/company/ilya-pharma, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes